Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters

Amy J. Eshleman, Emilie Stewart, Anna K. Evenson, John N. Mason, Randy D. Blakely, Aaron Janowsky, Kim Neve

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

To determine if catechol-O-methyltransferase (COMT) metabolizes catecholamines within cell lines used for heterologous expression of plasmalemmal transporters and alters the measured characteristics of 3H- substrate transport, the uptake of monoamine transporter substrates was assessed in three cell lines (C6 glioma, L-M fibroblast and HEK293 cells) that had been transfected with the recombinant human transporters. Uptake and cellular retention of 3H-catecholamines was increased by up to fourfold by two COMT inhibitors, tropolone and Ro 41-0960, with potencies similar to those for inhibition of COMT activity, whereas the uptake of two transporter substrates that are not substrates for COMT, [3H]serotonin and [3H]MPP+, was unaffected. Direct measurement of monoamine substrates by HPLC confirmed that tropolone (1 mM) increased the retention of the catecholamines dopamine and norepinephrine, but not the retention of serotonin in HEK293 cells. Saturation analysis of the uptake of [3H]dopamine by C6 cells expressing the dopamine transporter demonstrated that tropolone (1 mM) decreased the apparent K(m) of transport from 0.61 μM to 0.34 μM without significantly altering the maximal velocity of transport. These data suggest that endogenous COMT activity in mammalian cells may alter neurotransmitter deposition and thus the apparent kinetic characteristics of transport.

Original languageEnglish (US)
Pages (from-to)1459-1466
Number of pages8
JournalJournal of Neurochemistry
Volume69
Issue number4
StatePublished - Oct 1997

Fingerprint

Catechol O-Methyltransferase
Tropolone
Metabolism
Catecholamines
Cells
HEK293 Cells
Substrates
Dopamine
Serotonin
Cell Line
Dopamine Plasma Membrane Transport Proteins
Glioma
Neurotransmitter Agents
Fibroblasts
Norepinephrine
High Pressure Liquid Chromatography
Kinetics

Keywords

  • Catechol-O-methyltransferase
  • CDNA
  • Dopamine transporter
  • Tropolone

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters. / Eshleman, Amy J.; Stewart, Emilie; Evenson, Anna K.; Mason, John N.; Blakely, Randy D.; Janowsky, Aaron; Neve, Kim.

In: Journal of Neurochemistry, Vol. 69, No. 4, 10.1997, p. 1459-1466.

Research output: Contribution to journalArticle

Eshleman, Amy J. ; Stewart, Emilie ; Evenson, Anna K. ; Mason, John N. ; Blakely, Randy D. ; Janowsky, Aaron ; Neve, Kim. / Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters. In: Journal of Neurochemistry. 1997 ; Vol. 69, No. 4. pp. 1459-1466.
@article{38d64616acb549c28af3b2a96d5ae883,
title = "Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters",
abstract = "To determine if catechol-O-methyltransferase (COMT) metabolizes catecholamines within cell lines used for heterologous expression of plasmalemmal transporters and alters the measured characteristics of 3H- substrate transport, the uptake of monoamine transporter substrates was assessed in three cell lines (C6 glioma, L-M fibroblast and HEK293 cells) that had been transfected with the recombinant human transporters. Uptake and cellular retention of 3H-catecholamines was increased by up to fourfold by two COMT inhibitors, tropolone and Ro 41-0960, with potencies similar to those for inhibition of COMT activity, whereas the uptake of two transporter substrates that are not substrates for COMT, [3H]serotonin and [3H]MPP+, was unaffected. Direct measurement of monoamine substrates by HPLC confirmed that tropolone (1 mM) increased the retention of the catecholamines dopamine and norepinephrine, but not the retention of serotonin in HEK293 cells. Saturation analysis of the uptake of [3H]dopamine by C6 cells expressing the dopamine transporter demonstrated that tropolone (1 mM) decreased the apparent K(m) of transport from 0.61 μM to 0.34 μM without significantly altering the maximal velocity of transport. These data suggest that endogenous COMT activity in mammalian cells may alter neurotransmitter deposition and thus the apparent kinetic characteristics of transport.",
keywords = "Catechol-O-methyltransferase, CDNA, Dopamine transporter, Tropolone",
author = "Eshleman, {Amy J.} and Emilie Stewart and Evenson, {Anna K.} and Mason, {John N.} and Blakely, {Randy D.} and Aaron Janowsky and Kim Neve",
year = "1997",
month = "10",
language = "English (US)",
volume = "69",
pages = "1459--1466",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters

AU - Eshleman, Amy J.

AU - Stewart, Emilie

AU - Evenson, Anna K.

AU - Mason, John N.

AU - Blakely, Randy D.

AU - Janowsky, Aaron

AU - Neve, Kim

PY - 1997/10

Y1 - 1997/10

N2 - To determine if catechol-O-methyltransferase (COMT) metabolizes catecholamines within cell lines used for heterologous expression of plasmalemmal transporters and alters the measured characteristics of 3H- substrate transport, the uptake of monoamine transporter substrates was assessed in three cell lines (C6 glioma, L-M fibroblast and HEK293 cells) that had been transfected with the recombinant human transporters. Uptake and cellular retention of 3H-catecholamines was increased by up to fourfold by two COMT inhibitors, tropolone and Ro 41-0960, with potencies similar to those for inhibition of COMT activity, whereas the uptake of two transporter substrates that are not substrates for COMT, [3H]serotonin and [3H]MPP+, was unaffected. Direct measurement of monoamine substrates by HPLC confirmed that tropolone (1 mM) increased the retention of the catecholamines dopamine and norepinephrine, but not the retention of serotonin in HEK293 cells. Saturation analysis of the uptake of [3H]dopamine by C6 cells expressing the dopamine transporter demonstrated that tropolone (1 mM) decreased the apparent K(m) of transport from 0.61 μM to 0.34 μM without significantly altering the maximal velocity of transport. These data suggest that endogenous COMT activity in mammalian cells may alter neurotransmitter deposition and thus the apparent kinetic characteristics of transport.

AB - To determine if catechol-O-methyltransferase (COMT) metabolizes catecholamines within cell lines used for heterologous expression of plasmalemmal transporters and alters the measured characteristics of 3H- substrate transport, the uptake of monoamine transporter substrates was assessed in three cell lines (C6 glioma, L-M fibroblast and HEK293 cells) that had been transfected with the recombinant human transporters. Uptake and cellular retention of 3H-catecholamines was increased by up to fourfold by two COMT inhibitors, tropolone and Ro 41-0960, with potencies similar to those for inhibition of COMT activity, whereas the uptake of two transporter substrates that are not substrates for COMT, [3H]serotonin and [3H]MPP+, was unaffected. Direct measurement of monoamine substrates by HPLC confirmed that tropolone (1 mM) increased the retention of the catecholamines dopamine and norepinephrine, but not the retention of serotonin in HEK293 cells. Saturation analysis of the uptake of [3H]dopamine by C6 cells expressing the dopamine transporter demonstrated that tropolone (1 mM) decreased the apparent K(m) of transport from 0.61 μM to 0.34 μM without significantly altering the maximal velocity of transport. These data suggest that endogenous COMT activity in mammalian cells may alter neurotransmitter deposition and thus the apparent kinetic characteristics of transport.

KW - Catechol-O-methyltransferase

KW - CDNA

KW - Dopamine transporter

KW - Tropolone

UR - http://www.scopus.com/inward/record.url?scp=0030930379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030930379&partnerID=8YFLogxK

M3 - Article

C2 - 9326274

AN - SCOPUS:0030930379

VL - 69

SP - 1459

EP - 1466

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 4

ER -